Abnormal Angiogenesis in Diabetic Nephropathy

被引：192

作者：

Nakagawa, Takahiko ^{[1
]}

Kosugi, Tomoki ^{[1
]}

Haneda, Masakazu ^{[2
]}

Rivard, Christopher J. ^{[1
]}

Long, David A. ^{[3
]}

机构：

[1] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO USA

[2] Asahikawa Med Coll, Dept Internal Med 2, Asahikawa, Hokkaido 078, Japan

[3] UCL Inst Child Hlth, Nephro Urol Unit, London, England

来源：

DIABETES | 2009年 / 58卷 / 07期

基金：

美国国家卫生研究院;

关键词：

ENDOTHELIAL GROWTH-FACTOR; AMELIORATES RENAL ALTERATIONS; EPITHELIUM-DERIVED FACTOR; FACTOR GENE-EXPRESSION; NITRIC-OXIDE; FACTOR VEGF; GLOMERULAR HYPERTROPHY; STRUCTURAL-CHANGES; VASCULAR POLE; EARLY-STAGE;

D O I：

10.2337/db09-0119

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1471 / 1478

页数：8

共 75 条

[1]

ADVANI A, 2007, P NATL ACAD SCI US

[2] Retinal and choroidal microangiopathies: Therapeutic opportunities [J].

Afzal, A. ;

Shaw, L. C. ;

Ljubimov, A. V. ;

Boulton, M. E. ;

Segal, M. S. ;

Grant, M. B. .

MICROVASCULAR RESEARCH, 2007, 74 (2-3) :131-144

[3] Diabetic retinopathy [J].

Aiello, LP ;

Gardner, TW ;

King, GL ;

Blankenship, G ;

Cavallerano, JD ;

Ferris, FL ;

Klein, R .

DIABETES CARE, 1998, 21 (01) :143-156

[4] Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss [J].

Baelde, H. J. ;

Eikmans, M. ;

Lappin, D. W. P. ;

Doran, P. P. ;

Hohenadel, D. ;

Brinkkoetter, P-T ;

van der Woude, F. J. ;

Waldherr, R. ;

Rabelink, T. J. ;

de Heer, E. ;

Bruijin, J. A. .

KIDNEY INTERNATIONAL, 2007, 71 (07) :637-645

[5] Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy [J].

Baelde, HJ ;

Eikmans, M ;

Doran, PP ;

Lappin, DWP ;

de Heer, E ;

Bruijn, JA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :636-650

[6] Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation [J].

Bailey, E ;

Bottomley, MJ ;

Westwell, S ;

Pringle, JH ;

Furness, PN ;

Feehally, J ;

Brenchley, PEC ;

Harper, SJ .

JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (10) :735-738

[7] Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].

Bergers, G ;

Song, S ;

Meyer-Morse, N ;

Bergsland, E ;

Hanahan, D .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295

[8] Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes [J].

Bortoloso, E ;

Del Prete, D ;

Vestra, MD ;

Gambaro, G ;

Saller, A ;

Antonucci, F ;

Baggio, B ;

Anglani, F ;

Fioretto, P .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (06) :799-807

[9] Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide [J].

Bussolati, B ;

Dunk, C ;

Grohman, M ;

Kontos, CD ;

Mason, J ;

Ahmed, A .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03) :993-1008

[10] Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states - A possible explanation for impaired collateral formation in cardiac tissue [J].

Chou, E ;

Suzuma, I ;

Way, KJ ;

Opland, D ;

Clermont, AC ;

Naruse, K ;

Suzuma, K ;

Bowling, NL ;

Vlahos, CJ ;

Aiello, LP ;

King, GL .

CIRCULATION, 2002, 105 (03) :373-379

← 1 2 3 4 5 6 7 8 →